Company Overview
About Altos Labs
Altos Labs is a biotechnology company incorporated in 2021 and publicly launched in January 2022 with an extraordinary $3 billion Series A — the largest biotech launch funding round in history. The company is backed by Jeff Bezos and Yuri Milner, among others, and is headquartered in San Carlos, California, with research institutes in Cambridge, UK, and Japan. Altos Labs is focused on biological reprogramming and cellular rejuvenation — the scientific field exploring whether Yamanaka factors (a set of transcription factors that can reset a cell's epigenetic age) can be applied therapeutically to reverse disease progression and restore cellular function in aging tissues without causing cancer or loss of cell identity.
Business Model & Competitive Advantage
The company recruited a world-class scientific team including Nobel Laureate Shinya Yamanaka (who discovered the reprogramming factors in 2006) as a senior scientist and chairman of the scientific advisory board, along with prominent researchers from the Salk Institute, Stanford, Cambridge, and other leading institutions. Altos Labs' research program spans multiple organ systems — studying how partial reprogramming (brief expression of Yamanaka factors) can rejuvenate aged cells in the heart, liver, neurons, and other tissues while maintaining the cells' functional identity. The goal is to develop rejuvenation therapies that treat age-related diseases as a class rather than one disease at a time.
Competitive Landscape 2025–2026
Altos Labs operates as a research-stage company with a long time horizon — it is not developing products for near-term commercialization but building foundational scientific understanding of biological reprogramming. This distinguishes it from typical drug development biotechs and positions it more like a private research institute with a commercial mandate. Its competitors in the longevity and rejuvenation space include Calico (backed by Google), Retro Biosciences (backed by Sam Altman), and Unity Biotechnology, though Altos is notable for its scale of ambition and funding relative to the field.
Key Differentiators
Strong Challenger
Altos Labs is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Similar Brands
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Compare Altos Labs with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Altos Labs? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Altos Labs Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Altos Labs vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →